Developer of biotechnology therapeutics designed to treat immune-mediated diseases. The company maps human tissue's behavior to disease processes, allowing it to identify and characterize novel target...

Healthcare
San Francisco, CA, United States
Founded 2018
50 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$172.1M
Last Round
N/A

Get the full picture

Create a free account to unlock TRexBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required